VG Life Sciences Inc. Share Price Other OTC
Equities
VGLS
US91822T1016
Biotechnology & Medical Research
Sales 2013 | - | Sales 2014 | - | Capitalization | 2.23M 175M |
---|---|---|---|---|---|
Net income 2013 | -7M -550M | Net income 2014 | -6M -471M | EV / Sales 2013 | - |
Net Debt 2013 | 2.49M 196M | Net Debt 2014 | 3.83M 301M | EV / Sales 2014 | - |
P/E ratio 2013 |
-0.25
x | P/E ratio 2014 |
-0.31
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Stricklandd
BRD | Director/Board Member | 48 | 31/12/16 |
Ana Gois
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Stricklandd
BRD | Director/Board Member | 48 | 31/12/16 |
1st Jan change | Capi. | |
---|---|---|
+44.48% | 55.07B | |
+43.74% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |